Powell Chelsea E, Du Guangyan, Bushman Jonathan W, He Zhixiang, Zhang Tinghu, Fischer Eric S, Gray Nathanael S
Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School Boston Massachusetts 02115 USA.
Department of Cancer Biology, Dana-Farber Cancer Institute Boston Massachusetts 02215 USA
RSC Med Chem. 2021 Jul 6;12(8):1381-1390. doi: 10.1039/d0md00382d. eCollection 2021 Aug 18.
Targeted protein degradation represents a rapidly growing area in drug discovery and development. Moreover, small molecules that induce the targeted degradation of a given protein also represent an important addition to the chemical probes toolbox as these compounds can achieve selective protein knockdown, thus providing an approach that is orthogonal to genetic knockdowns. In order to develop degradation-inducing chemical probes for studying cereblon (CRBN) biology, we generated six CRBN-CRBN (homo-PROTAC) degraders and six CRBN-VHL (hetero-PROTAC) degraders. From these compounds we identified two potent and selective CRBN degraders ( and ), both of which are CRBN-VHL compounds. We characterized these lead degraders by quantitative proteomics in five cell lines (MM1.S, Kelly, SK-N-DZ, HEK293T, and MOLT-4) and observed high selectivity for CRBN in all cell lines. Furthermore, we directly compared our compounds to current lead CRBN degraders and demonstrated how these probes can be used as chemical knockdown reagents for studying CRBN-dependent processes. Overall, our work provides a roadmap for thorough degrader characterization by combination western and proteomic analysis, as illustrated by the identification of and as CRBN-knockdown tool compounds suitable for cell-based studies.
靶向蛋白质降解是药物研发中一个快速发展的领域。此外,能够诱导特定蛋白质靶向降解的小分子也是化学探针工具库的重要补充,因为这些化合物可以实现选择性蛋白质敲低,从而提供一种与基因敲低正交的方法。为了开发用于研究cereblon(CRBN)生物学的降解诱导化学探针,我们生成了六种CRBN-CRBN(同型PROTAC)降解剂和六种CRBN-VHL(异型PROTAC)降解剂。从这些化合物中,我们鉴定出两种强效且选择性的CRBN降解剂(和),它们都是CRBN-VHL化合物。我们通过定量蛋白质组学在五种细胞系(MM1.S、Kelly、SK-N-DZ、HEK293T和MOLT-4)中对这些先导降解剂进行了表征,并在所有细胞系中观察到对CRBN的高选择性。此外,我们将我们的化合物与当前的先导CRBN降解剂进行了直接比较,并展示了这些探针如何用作化学敲低试剂来研究CRBN依赖性过程。总体而言,我们的工作通过蛋白质免疫印迹和蛋白质组学分析相结合,为全面表征降解剂提供了路线图,如鉴定出和作为适用于基于细胞研究的CRBN敲低工具化合物所示。